BR112012025590A2 - análogos de pirimidinilpiperidiniloxipiridinona como moduladores de gpr119 - Google Patents
análogos de pirimidinilpiperidiniloxipiridinona como moduladores de gpr119Info
- Publication number
- BR112012025590A2 BR112012025590A2 BR112012025590A BR112012025590A BR112012025590A2 BR 112012025590 A2 BR112012025590 A2 BR 112012025590A2 BR 112012025590 A BR112012025590 A BR 112012025590A BR 112012025590 A BR112012025590 A BR 112012025590A BR 112012025590 A2 BR112012025590 A2 BR 112012025590A2
- Authority
- BR
- Brazil
- Prior art keywords
- gpr119
- coupled receptor
- pyrimidinylpiperidinyloxypyridinone
- analogues
- modulators
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Abstract
análogos de pirimidinilpiperidiniloxipiridinona como moduladores de gpr119. a presente invenção refere-se a compostos de fórmula estrutural ou um enantiômero, um diastereômero, ou um sal farmaceuticamente aceitável dos mesmos, em que, n~ 1~, r^ 1^, r^ 2^, r^ 3^ e r^ 4^ são definidos aqui, são fornecidos os quais são moduladores de receptor acoplado à proteína g gpr119. moduladores de receptor acoplado à proteína g gpr119 são úteis no tratamento, prevenção, ou retardo da progressão de doenças que requerem terapia moduladora de receptor acoplado à proteína g gpr119. desse modo, a descrição também diz respeito a composições compreendendo estes novos compostos e métodos de tratar doenças ou condições relacionadas à atividade do receptor acoplado à proteína g gpr119 usando-se quaisquer destes novos compostos ou uma composição compreendendo quaisquer de tais novos compostos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32194610P | 2010-04-08 | 2010-04-08 | |
PCT/US2011/031320 WO2011127106A1 (en) | 2010-04-08 | 2011-04-06 | Pyrimidinylpiperidinyloxypyridinone analogues as gpr119 modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112012025590A2 true BR112012025590A2 (pt) | 2016-06-21 |
Family
ID=44021850
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012025590A BR112012025590A2 (pt) | 2010-04-08 | 2011-04-06 | análogos de pirimidinilpiperidiniloxipiridinona como moduladores de gpr119 |
Country Status (14)
Country | Link |
---|---|
US (1) | US8415367B2 (pt) |
EP (1) | EP2556069B1 (pt) |
JP (1) | JP2013523822A (pt) |
CN (1) | CN102933576A (pt) |
AR (1) | AR081819A1 (pt) |
BR (1) | BR112012025590A2 (pt) |
CA (1) | CA2795732A1 (pt) |
EA (1) | EA201270755A1 (pt) |
IL (1) | IL222220A0 (pt) |
MX (1) | MX2012011460A (pt) |
SG (1) | SG184168A1 (pt) |
TW (1) | TW201136917A (pt) |
UY (1) | UY33323A (pt) |
WO (1) | WO2011127106A1 (pt) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201006821A (en) * | 2008-07-16 | 2010-02-16 | Bristol Myers Squibb Co | Pyridone and pyridazone analogues as GPR119 modulators |
WO2012131005A1 (en) * | 2011-03-29 | 2012-10-04 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Pharmaceutical composition of sitagliptin |
EP2718279B1 (en) | 2011-06-09 | 2016-08-10 | Rhizen Pharmaceuticals SA | Novel compounds as modulators of gpr-119 |
WO2013173198A1 (en) * | 2012-05-16 | 2013-11-21 | Bristol-Myers Squibb Company | Pyrimidinylpiperidinyloxypyridone analogues as gpr119 modulators |
CA2878625A1 (en) | 2012-07-11 | 2014-01-16 | Elcelyx Therapeutics, Inc. | Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk |
WO2014052619A1 (en) * | 2012-09-27 | 2014-04-03 | Irm Llc | Piperidine derivatives and compositions as modulators of gpr119 activity |
AR092742A1 (es) | 2012-10-02 | 2015-04-29 | Intermune Inc | Piridinonas antifibroticas |
CN104418769A (zh) * | 2013-09-03 | 2015-03-18 | 苏州安尼康药物研发有限公司 | 一种化合物及其制备方法 |
CN105968055B (zh) * | 2016-07-26 | 2018-08-28 | 中国科学院长春应用化学研究所 | 一种芳基嘧啶及其衍生物的制备方法 |
IL298306A (en) | 2020-05-19 | 2023-01-01 | Kallyope Inc | ampk operators |
JP2023531726A (ja) | 2020-06-26 | 2023-07-25 | キャリーオペ,インク. | Ampkアクチベーター |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3826643A (en) | 1967-08-07 | 1974-07-30 | American Cyanamid Co | Method of controlling undesirable plant species using 3-nitropyridines |
US5776983A (en) | 1993-12-21 | 1998-07-07 | Bristol-Myers Squibb Company | Catecholamine surrogates useful as β3 agonists |
US5488064A (en) | 1994-05-02 | 1996-01-30 | Bristol-Myers Squibb Company | Benzo 1,3 dioxole derivatives |
US5612359A (en) | 1994-08-26 | 1997-03-18 | Bristol-Myers Squibb Company | Substituted biphenyl isoxazole sulfonamides |
US5491134A (en) | 1994-09-16 | 1996-02-13 | Bristol-Myers Squibb Company | Sulfonic, phosphonic or phosphiniic acid β3 agonist derivatives |
US5541204A (en) | 1994-12-02 | 1996-07-30 | Bristol-Myers Squibb Company | Aryloxypropanolamine β 3 adrenergic agonists |
US5620997A (en) | 1995-05-31 | 1997-04-15 | Warner-Lambert Company | Isothiazolones |
WO1997012613A1 (en) | 1995-10-05 | 1997-04-10 | Warner-Lambert Company | Method for treating and preventing inflammation and atherosclerosis |
US5770615A (en) | 1996-04-04 | 1998-06-23 | Bristol-Myers Squibb Company | Catecholamine surrogates useful as β3 agonists |
US6566384B1 (en) | 1996-08-07 | 2003-05-20 | Darwin Discovery Ltd. | Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity |
TW536540B (en) | 1997-01-30 | 2003-06-11 | Bristol Myers Squibb Co | Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe |
UA57811C2 (uk) | 1997-11-21 | 2003-07-15 | Пфайзер Продактс Інк. | Фармацевтична композиція, що містить інгібітор альдозоредуктази та інгібітор глікогенфосфорилази (варіанти), комплект, який її включає, та способи лікування ссавців зі станом інсулінорезистентності |
EP2002837A1 (en) | 1998-07-06 | 2008-12-17 | Bristol-Myers Squibb Company | Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
EP1058549A4 (en) | 1998-12-23 | 2003-11-12 | Bristol Myers Squibb Pharma Co | FACTOR Xa OR THROMBIN INHIBITORS |
CA2413241A1 (en) | 2000-06-29 | 2002-01-10 | Bristol-Myers Squibb Pharma Company | Thrombin or factor xa inhibitors |
AU2002218509A1 (en) | 2000-12-01 | 2002-06-11 | Yamanouchi Pharmaceutical Co..Ltd. | Method of screening remedy for diabetes |
US7482366B2 (en) | 2001-12-21 | 2009-01-27 | X-Ceptor Therapeutics, Inc. | Modulators of LXR |
CA2469435A1 (en) | 2001-12-21 | 2003-07-24 | X-Ceptor Therapeutics, Inc. | Modulators of lxr |
SG182004A1 (en) | 2003-01-14 | 2012-07-30 | Arena Pharm Inc | 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
CN1751038A (zh) | 2003-02-24 | 2006-03-22 | 艾尼纳制药公司 | 作为葡萄糖代谢调节剂的经取代芳基和杂芳基衍生物及葡萄糖代谢失调的预防和治疗 |
SE0301010D0 (sv) | 2003-04-07 | 2003-04-07 | Astrazeneca Ab | Novel compounds |
AR045047A1 (es) | 2003-07-11 | 2005-10-12 | Arena Pharm Inc | Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos |
BRPI0412689A (pt) | 2003-07-14 | 2006-10-03 | Arena Pharm Inc | derivados de heteroarila e arila fundida como moduladores de metabolismo e a profilaxia e tratamento de distúrbios relacionados a ele |
US20070088163A1 (en) | 2003-09-12 | 2007-04-19 | Kemia, Inc. | Modulators of calcitonin and amylin activity |
US20080269114A1 (en) | 2004-03-17 | 2008-10-30 | 7Tm Pharma A/S | Y4 Selective Receptor Agonists For Thereapeutic Interventions |
ES2329489T3 (es) | 2004-05-03 | 2009-11-26 | F. Hoffmann-La Roche Ag | Derivados de indolilo como moduladores del receptor x del higado. |
CA2568451A1 (en) | 2004-06-04 | 2005-12-22 | Arena Pharmaceuticals, Inc. | Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
WO2006067532A1 (en) | 2004-12-24 | 2006-06-29 | Prosidion Ltd | G-protein coupled receptor agonists |
MY148521A (en) | 2005-01-10 | 2013-04-30 | Arena Pharm Inc | Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto |
US20060292073A1 (en) | 2005-06-23 | 2006-12-28 | Emory University | Stereoselective Synthesis of Amino Acid Analogs for Tumor Imaging |
EP1907384A2 (en) | 2005-06-30 | 2008-04-09 | Prosidion Limited | Gpcr agonists |
EP2152707B1 (en) | 2007-05-04 | 2012-06-20 | Bristol-Myers Squibb Company | [6,5]-bicyclic gpr119 g protein-coupled receptor agonists |
ES2388967T3 (es) | 2007-05-04 | 2012-10-22 | Bristol-Myers Squibb Company | Agonistas [6,6]- y [6,7]-bicíclicos del receptor GPR119 acoplado a la proteína G |
WO2009012275A1 (en) | 2007-07-17 | 2009-01-22 | Bristol-Myers Squibb Company | Pyridone gpr119 g protein-coupled receptor agonists |
TW201006821A (en) | 2008-07-16 | 2010-02-16 | Bristol Myers Squibb Co | Pyridone and pyridazone analogues as GPR119 modulators |
-
2011
- 2011-04-06 SG SG2012069746A patent/SG184168A1/en unknown
- 2011-04-06 BR BR112012025590A patent/BR112012025590A2/pt not_active Application Discontinuation
- 2011-04-06 US US13/080,758 patent/US8415367B2/en active Active
- 2011-04-06 CA CA2795732A patent/CA2795732A1/en not_active Abandoned
- 2011-04-06 MX MX2012011460A patent/MX2012011460A/es active IP Right Grant
- 2011-04-06 EA EA201270755A patent/EA201270755A1/ru unknown
- 2011-04-06 JP JP2013503864A patent/JP2013523822A/ja not_active Withdrawn
- 2011-04-06 CN CN2011800285354A patent/CN102933576A/zh active Pending
- 2011-04-06 WO PCT/US2011/031320 patent/WO2011127106A1/en active Application Filing
- 2011-04-06 EP EP11715129.0A patent/EP2556069B1/en not_active Not-in-force
- 2011-04-08 TW TW100112288A patent/TW201136917A/zh unknown
- 2011-04-08 AR ARP110101204A patent/AR081819A1/es not_active Application Discontinuation
- 2011-04-08 UY UY0001033323A patent/UY33323A/es unknown
-
2012
- 2012-09-27 IL IL222220A patent/IL222220A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
EA201270755A1 (ru) | 2013-03-29 |
IL222220A0 (en) | 2012-12-31 |
SG184168A1 (en) | 2012-10-30 |
JP2013523822A (ja) | 2013-06-17 |
US20110251221A1 (en) | 2011-10-13 |
WO2011127106A1 (en) | 2011-10-13 |
CA2795732A1 (en) | 2011-10-13 |
AR081819A1 (es) | 2012-10-24 |
US8415367B2 (en) | 2013-04-09 |
MX2012011460A (es) | 2012-11-23 |
UY33323A (es) | 2011-10-31 |
TW201136917A (en) | 2011-11-01 |
EP2556069A1 (en) | 2013-02-13 |
EP2556069B1 (en) | 2015-04-01 |
CN102933576A (zh) | 2013-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012025590A2 (pt) | análogos de pirimidinilpiperidiniloxipiridinona como moduladores de gpr119 | |
BR112012028445A2 (pt) | compostos de heteroarila bicíclica como moduladores de gpr119 | |
BR112012007979A2 (pt) | moduladores de gpr40 de pirrolidina | |
BR112015011031A2 (pt) | moduladores de grp40 de di-hidropirazol | |
BR112015015468B8 (pt) | Composto, e, composição farmacêutica | |
EA201200406A1 (ru) | Соединения и композиции, которые являются модуляторами активности tlr | |
EA200901032A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
CA2797033C (en) | Highly active polypeptides and methods of making and using the same | |
BR112012011072A2 (pt) | inibidores de n1-pirazolospirocetona acetil-coa carboxilase | |
BR112012027034A2 (pt) | inibidores da arginase e suas aplicações terapêuticas | |
BR112016009630A8 (pt) | receptores de farnesoide x, seus usos, composição farmacêutica, e combinação | |
EA201791916A1 (ru) | 2'-замещенные карбануклеозидные аналоги для противовирусного лечения | |
BRPI0518222A (pt) | composto, processo para a sua manufatura, composições farmacêuticas que os compreendem, método para o tratamento e/ou prevenção de enfermidades que estão associadas com a modulação de receptores de h3 e utilização dos mesmos | |
BR112012019762A2 (pt) | composto, composição, e, método para tratar uma doença. | |
EA200901166A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr 119 | |
BR112014018879A8 (pt) | Composto e composição farmacêutica e combinação compreendendo dito composto | |
BR112015000578A2 (pt) | moduladores da via do complemento e usos dos mesmos | |
BRPI0910388A2 (pt) | agentes terapêutico antivirais. | |
BR112015010791A2 (pt) | moduladores de gpr40 de di-hidropirazol | |
BR112013003847A8 (pt) | métodos de tratar a deterioração cognitiva moderada (mci) e os distúrbios relacionados | |
EA201692506A2 (ru) | Ингибиторы репликации вирусов гриппа | |
BR112013006344A2 (pt) | lactamas substituídas por piperdinila como moduladores de gpr119, composição farmacêutica as compreendendo, uso e processso para preparação das mesmas | |
BR112015010649A2 (pt) | moduladores de gpr40 à base de pirrolidina | |
BR112015010779A2 (pt) | moduladores de di-hidropirazol gpr40 | |
BR112012021364A2 (pt) | "compostos cicloalquila contendo tienopirimidinas e composições farmacêuticas". |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |